It follows then in pathological condition like prostate cancer, AR-V7 is selected to restore AR signaling in androgen depleted conditions, which effectively transforms the tumor microenvironment to an emergent/chronic wound repair status by regulating expression of genes like TNC resulting in hormone independent growth, survival, and progression [65]. The gene discussed is AR; the disease is prostate carcinoma.